An Israeli company that is developing a breakthrough radiation cancer therapy got a huge boost with a $26 million investment to bring it closer to getting the new treatment to market.
Jerusalem-based Alpha Tau Medical recently completed successful human clinical trials of its “Alpha DaRT” system on cancer patients from Italy and Israel, with the impressive results getting great feedback after being published in leading medical journals.
Full Story (United with Israel)
